首页> 外文OA文献 >Glycoprotein IIb / IIIa inhibitors use in the setting of primary percutaneous coronary intervention for ST elevation myocardial infarction in patients pre‐treated with newer P2Y12 inhibitors

【2h】

Glycoprotein IIb / IIIa inhibitors use in the setting of primary percutaneous coronary intervention for ST elevation myocardial infarction in patients pre‐treated with newer P2Y12 inhibitors

机译：糖蛋白IIB / IIIA抑制剂用于患者预处理P2Y12抑制剂预处理的患者的ST升高冠状动脉介入的初步经皮冠状动脉介入的抑制剂

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Katrien Blanchart; Thibaut Heudel; Pierre Ardouin; Adrien Lemaitre; Clément Briet; Mathieu Bignon; Rémi Sabatier; Damien Legallois; Vincent Roule; Farzin Beygui;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention [J] . A. S. Tereshchenko, Е. V. Merkulov, A. M. Samko Racional?naa Farmakoterapia v Kardiologii . 2020,第6期

机译：糖蛋白IIB / IIIA受体抑制剂在患者中患者抬高心肌梗死和初生经皮冠状动脉介入
2. Meta-Analysis of Randomized Trials of Intracoronary Versus Intravenous Glycoprotein IIb/IIIa Inhibitors in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention [J] . Elbadawi Ayman, Elgendy Islam Y., Megaly Michael, The American Journal of Cardiology . 2017,第7期

机译：在患有初级经皮冠状动脉介入的患者中，intacoronary的随机试验与静脉内糖蛋白IIB / IIIA抑制剂的荟萃分析
3. Glycoprotein IIb/IIIa inhibitors with or without thienopyridine pretreatment improve outcomes after primary percutaneous coronary intervention in high-risk patients with ST elevation myocardial infarction - A meta-regression of randomized controlled trials [J] . SethiA., BajajA., BahekarA., Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions . 2013,第2期

机译：糖蛋白IIb / IIIa抑制剂联合或不联合噻吩并吡啶预处理可改善高危ST段抬高型心肌梗死患者初次经皮冠状动脉介入治疗后的结局-随机对照试验的Meta回归
4. Impact of Renal Insufficiency on 30-Day Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention [C] . Sakai K., Tosaka A., Soga Y., World Congress on Heart Disease. . 2013

机译：肾功能不全对初级经皮冠状动脉干预治疗的ST段升高心肌梗死患者30天后的影响
5. Meta-analysis: The impact of thrombectomy during PCI (percutaneous coronary intervention) on mortality, re-infarction and target vessel revascularization among patients with ST elevation myocardial infarction compared with standard PCI. [D] . Martar, Martar. 2016

机译：荟萃分析：与标准PCI相比，ST抬高型心肌梗死患者在PCI（经皮冠状动脉介入治疗）期间进行血栓切除术对死亡率，再梗塞和靶血管血运重建的影响。
6. Clinical Benefit of Low Molecular Weight Heparin for ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention with Glycoprotein IIb/IIIa Inhibitor [O] . Jung Sun Cho, Sung-Ho Her, Ju Yeal Baek, 2010

机译：低分子量肝素对接受糖蛋白IIb / IIIa抑制剂经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的临床益处
7. A Study of 1,236 Patients Supporting the Use of Unfractionated Heparin With or Without Glycoprotein IIb/IIIa Inhibitors over Bivalirudin in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Changing Trend [O] . Akkad Isaac 2017

机译：对1,236名患者的研究，支持使用未分支肝素，在初生经皮冠状动脉介入中对糖蛋白IIB / IIIA抑制剂进行糖蛋白的抑制剂进行ST段抬高心肌梗死：变化趋势

Glycoprotein IIb / IIIa inhibitors use in the setting of primary percutaneous coronary intervention for ST elevation myocardial infarction in patients pre‐treated with newer P2Y12 inhibitors

著录项

引文网络

相似文献

相关主题

期刊订阅